Cancer therapeutics as precise as their targets

all companies
milestones

Founded 2020

Partnered 2021

Team

Kevin Parker

Board
LEAD INVESTOR
category
Oncology
Immunology

Shaping a world in which cancer immunotherapies are designed around and directed toward the safest and most effective targets

No items found.